ArticlePharmaceuticals (Basel, Switzerland)2025

Therapeutic Potential of Qilianxiaopi Formula: Targeting ADAM17-Mediated Chronic Inflammation in Atrophic Gastritis.

Sijing Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.